Brief Title
German Adrenocortical Carcinoma Registry
Official Title
Deutsches Nebennieren-Karzinom-Register - German Adrenocortical Carcinoma Registry
Brief Summary
Basic objective of the German Adrenocortical Carcinoma Registry is to improve the care of
patients with adrenocortical cancer. The registration of as many patients as possible helps
to collect data for the prognosis and prospects of success regarding different treatment
plans. This data will be taken into consideration for planning prospective studies. With this
registry, the recruitment of patients for prospective studies will be significantly
facilitated. In this way - and in cooperation with networks in other countries (e.g. in Italy
and France) - a structure allowing systematic improvement of therapy will be developed.
Study Type
Observational
Condition
Adrenocortical Carcinoma
Study Arms / Comparison Groups
Adrenocortical carcinoma
Description: Adrenocortical carcinoma
Publications
* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
Recruitment Information
Estimated Enrollment
1000
Start Date
January 2003
Completion Date
December 2025
Primary Completion Date
December 2023
Eligibility Criteria
Inclusion Criteria:
- Histologically confirmed diagnosis of adrenocortical carcinoma
Gender
All
Ages
N/A - N/A
Accepts Healthy Volunteers
No
Contacts
Martin Fassnacht, MD, 49-931-201-36507, [email protected]
Location Countries
Germany
Location Countries
Germany
Administrative Informations
NCT ID
NCT00453674
Organization ID
Wue-ACC-R-86-03
Responsible Party
Principal Investigator
Study Sponsor
University of Wuerzburg
Collaborators
Deutsche Krebshilfe e.V., Bonn (Germany)
Study Sponsor
Martin Fassnacht, MD, Principal Investigator, University of Wuerzburg
Verification Date
August 2018